Kolkata, West Bengal -- (SBWIRE) -- 09/10/2013 -- Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on Nokia Corporation (ADR)(NYSE:NOK), National Bank of Greece (ADR)(NYSE:NBG), MannKind Corporation(NASDAQ:MNKD).
Nokia Corporation (ADR)(NYSE:NOK) shares jumped 2.79% to $5.52. The company has on September 6, 2013 received a flagging notification in accordance with Chapter 9, section 5 of the Finnish Securities Markets Act from Microsoft Corporation (NASDAQ:MSFT). As announced on September 3, 2013 Microsoft has made available to Nokia EUR 1.5 billion financing in the form of convertible bonds to be issued by Nokia. Each tranche is of nominal value of EUR 500 million maturing in 2018 (“2018 Bond”), in 2019 (“2019 Bond”) and in 2020 (“2020 Bond”), respectively.
Should Investors Buy NOK After Yesterday’s Slump? Find Out Here
Additionally, Microsoft Corporation (NASDAQ:MSFT) on Sept. 3 announced its agreement to acquire Nokia Corporation (ADR) (NYSE:NOK)’s Devices and Services section, including the right to license the patent and to use the mapping services, for €5.44 billion. Under the terms of the agreement, the software giant will also acquire the mobile phone and smartphone business units including the Lumia & Asha brands and related production facilities of the Finnish smartphone manufacturer.
National Bank of Greece (ADR)(NYSE:NBG) shares gained 7% to $4.28. The company on August 29 said that a strong performance by its Turkish subsidiary helped boost first-half profits to 344 million euros ($455 million), after deep losses a year ago. The company said its Turkish Finansbank unit recorded a 30% increase in first-half profits to 332 million euros.
How Should Investors Trade MSFT After The Recent Volatility? Get Free Report Here
The bank also said its overall provisions for bad loans fell from 1.2 billion euros a year ago to 853 million in January-June. In the first half of 2012, NBG recorded losses of 1.9 billion euros.
Additionally, the company on June 14 said it had raised enough money from private investors in a share offering to ensure it avoids state control. NBG is the second major Greek lender to successfully recapitalise without falling under the full control of the Hellenic Financial Stability Fund (HFSF), a vehicle to rescue Greek banks under an EU/IMF bailout plan.
MannKind Corporation(NASDAQ:MNKD) shares jumped 2.05% to $5.98. The company on August 14 reported positive preliminary results from Study 171, a Phase 3 clinical study of AFREZZA Inhalation Powder, an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's next-generation (Gen2) inhaler (also known as the Dreamboat™ inhaler), in patients with type 1 diabetes.
Is MNKD A Good Buy After The Recent Price Movement? Find Out Here
Additionally, the company will present at The Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2013 at 3:30 PM (ET) at the Grand Hyatt Hotel in New York City.
Moreover, the company on August 9 reported financial results for the second quarter ended June 30, 2013. The net loss for the second quarter of 2013 was $46.1 million, or $0.16 per share, as compared with a net loss of $36.6 million, or $0.23 per share based on 159.9 million.
Specialpennystockalert.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Specialpennystockalert.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at Specialpennystockalert.com.
The assembled information disseminated by Specialpennystockalert.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Specialpennystockalert.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)